Price Chart

Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
URL http://www.hologic.com
Investor Relations URL https://investors.hologic.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Mid Cap/Blend
Next Earnings Release Nov. 04, 2024
Last Earnings Release Nov. 04, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
URL http://www.hologic.com
Investor Relations URL https://investors.hologic.com
HQ State/Province Massachusetts
Sector Health Care
Industry Health Care Equipment & Supplies
Equity Style Mid Cap/Blend
Next Earnings Release Nov. 04, 2024
Last Earnings Release Nov. 04, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A